Drug Duo Approved for Aggressive Thyroid Cancer

FRIDAY, May 4, 2018 — Two anti-cancer drugs administered together have been approved by the U.S. Food and Drug Administration to treat an inherited form of thyroid cancer.
Tafinlar (dabrafenib) and Mekinist (trametinib) combined have been approved…
Source: Topamax